CausalSentinel

Protein Dossier — CCL5 (C-C motif chemokine 5)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Neo-agreeableness -0.811 0.237 6.11e-04 Wald ratio 1 cis NA
Body mass index (BMI) 0.0309 0.00902 6.16e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertrophic cardiomyopathy (hcm or hocm) 0.91 0.278 0.00107 Wald ratio 1 cis NA
Birth weight 0.0364 0.0133 0.00616 Wald ratio 1 cis NA
Fractured bone site(s): Wrist 0.143 0.056 0.0106 Wald ratio 1 cis NA
Percent emphysema 0.0749 0.0309 0.0155 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0535 0.0231 0.0208 Wald ratio 1 cis NA
Autism 0.243 0.105 0.021 Wald ratio 1 cis NA
Vascular or heart problems diagnosed by doctor: Angina 0.104 0.0457 0.0225 Wald ratio 1 cis NA
Birth length 0.0798 0.0379 0.0351 Wald ratio 1 cis NA
Sleep duration -0.0145 0.00704 0.0394 Wald ratio 1 cis NA
Non-cancer illness code self-reported: arthritis (nos) 0.18 0.0875 0.0395 Wald ratio 1 cis NA
…and 102 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2523_31_3 RANTES Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

11 association rows across 10 traits (11 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating CCL5 levels 6e-179 rs2107538 1 GCST90860445 no MR -> candidate analysis
CCL5 protein levels 2e-169 rs2107538 1 GCST90468584 no MR -> candidate analysis
Dynorphin A (1-17) levels 7e-107 rs2107538 1 GCST90247380 no MR -> candidate analysis
Delta-like protein 3 levels 2e-73 rs3817655 1 GCST90247295 no MR -> candidate analysis
C-C motif chemokine 5 levels 2e-67 rs7211393 2 GCST90246920 no MR -> candidate analysis
Blood protein levels 5e-35 rs2107538 1 GCST006585 no MR -> candidate analysis
Reticulocyte percentage (UKB data field 30240) 1e-14 rs41471045 1 GCST90468101 no MR -> candidate analysis
Reticulocyte count (UKB data field 30250) 1e-14 rs41471045 1 GCST90468100 no MR -> candidate analysis
CCL16 protein levels 2e-12 rs28914803 1 GCST90468568 no MR -> candidate analysis
C-C motif chemokine 5 (analyte X5480.49) levels 2e-10 rs1800825 1 GCST90426363 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1352 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
poisoning 0.261 common-variant locus no MR -> candidate analysis

Of the 1 rows above, 1 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (C-C motif chemokine 5)
gnomAD constraint pLI=0.085, LOEUF=1.16 — LoF-tolerant
GWAS Catalog 84 unique SNPs / 165 rows
ClinVar 28 records; 7 pathogenic in sample of 28
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance